Neurociencia del consumo y dependencia de sustancias psicoactivas

6. TRASTORNOS CONCURRENTES
Hall RG y colab. (1995) Level of functioning, severity of illness, and smoking
status among chronic psychiatric patients. Journal of Nervous and Mental
Disorders, 183:468–471.
Hambrecht M, Hafner H (1996) Substance abuse and the onset of schizophrenia.
Biological Psychiatry, 40:1155–1163.
Harris GC, Aston-Jones G (1994) Involvement of D2 dopamine receptors in the
nucleus accumbens in the opiate withdrawal syndrome. Nature, 371:155–157.
Harrison AA, Liem YT, Markou A (2001) Fluoxetine combined with a serotonin-1A
receptor antagonist reversed reward deficits observed during nicotine
and amphetamine withdrawal in rats. Neuropsychopharmacology, 25:55–71.
Harvey PD, Keefe RS (2001) Studies of cognitive change in patients with schizophrenia
following novel antipsychotic treatment. American Journal of Psychiatry,
158:176–184.
Hazlett EA y colab. (2000) Hypofrontality in unmedicated schizophrenia
patients studied with PET during performance of a serial verbal learning task.
Schizophrenia Research, 43:33–46.
Heckers S (2001) Neuroimaging studies of the hippocampus in schizophrenia.
Hippocampus, 11:520–528.
Heilig M, Widerlov E (1990) Neuropeptide Y: an overview of central distribution,
functional aspects, and possible involvement in neuropsychiatric illnesses.
Acta Psychiatrica Scandinavica, 82:95–114.
Heilig M y colab. (1994) Corticotropin-releasing factor and neuropeptide Y: role
in emotional integration. Trends in Neuroscience, 17:80–85.
Hendrie CA, Sairally J, Starkey N (1998) Self-medication with alcohol appears
not to be an effective treatment for the control of depression. Journal of
Psychopharmacology, 12:108.
Heninger GR, Delgado PL, Charney DS (1996) The revised monoamine theory
of depression: a modulatory role for monoamines, based on new findings
from monoamine depletion experiments in humans. Pharmacopsychiatry,
29:2–11.
Henningfield JE, Johnson RE, Jasinski DR (1987) Clinical procedures for the
assessment of abuse potential. En: Bozarth MA, ed. Methods of assessing the reinforcing
properties of abused drugs. Nueva York, NY, EE.UU. Springer-
Verlag:573–590.
Himmelsbach CK (1943) Can the euphoric, analgetic, and physical dependence
effects of drugs be separated? IV. With reference to physical dependence.
Federation Proceedings, 2:201–203.
Hitsman B y colab. (1999) Antidepressant pharmacotherapy helps some cigarette
smokers more than others. Journal of Consulting and Clinical Psychology,
67:547–554.
Holden C (2001) Drug addiction: zapping memory center triggers drug craving.
Science, 292:1039.
Hughes JR (1992) Tobacco withdrawal in self-quitters. Journal of Consulting and
Clinical Psychology, 60:689–697.
197